Phase I single-ascending dose study of VT 1161 in healthy volunteers

Trial Profile

Phase I single-ascending dose study of VT 1161 in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Sep 2013

At a glance

  • Drugs VT 1161 (Primary)
  • Indications Vulvovaginal candidiasis
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 10 Sep 2013 New trial record
    • 05 Sep 2013 Status changed from recruiting to completed. VT 1161 recently completed phase I clinical testing, according to a Viamet Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top